Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00516919 · ClinicalTrials.gov registry record · Phase 4

Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

A Phase 4 study, sponsored by Yale University.

Completed
Registry status
Phase 4
Development phase
79
Enrollment target

NCT00516919: Completed Phase 4 study, sponsored by Yale University.

NCT00516919 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 79 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00516919, a Phase 4 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 4
Development phase
79 participants
Enrollment target

Study Summary

This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.

Primary Outcome

Body Mass Index (BMI)

Interventions

  • DRUG Xenical + behavioral intervention
  • BEHAVIORAL Behavioral intervention + placebo

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2007-08
Est. Completion 2010-12
Phase Phase 4
Yale University

1,492 total trials

What the finished NCT00516919 record still lists

NCT00516919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Xenical + behavioral intervention is the first listed.

NCT00516919 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00516919 about?

NCT00516919 is a clinical study titled "Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons". This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.

What is the current status of trial NCT00516919?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2007-08. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00516919?

The interventions under investigation include: Xenical + behavioral intervention (DRUG), Behavioral intervention + placebo (BEHAVIORAL).

Who is sponsoring clinical trial NCT00516919?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00516919's enrollment target sits among peer trials

79 980th of 2000 higher than 1,019 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00516919, the US trial registry maintained by the National Library of Medicine. NCT00516919 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.